Search Results - morpholino

1 Results

Sort By:

Morpholino Oligomers to Prevent and Treat Coronavirus Infection

This technology licensing opportunity relates to antisense agents for treating or preventing a SARS-CoV-2 infection. The antisense agents are peptide-conjugated morpholino oligomers targeting pre-mRNA of a host (human) gene that encodes a protease. Some antisense agents included within the scope of this technology include agents previously shown to...

Published: 7/30/2025 | Inventor(s): Hong Moulton, David Stein, Eva Bottcher-Friebershauser

Keywords(s): Morpholino, SARS-CoV-2, Therapeutic

Category(s): Therapeutics